Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Published Date: 18 Oct 2024

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Glioblastoma treatment breakthrough shows promise

2.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

3.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

4.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

5.

Universal screening approach achieves a comparable detection rate of lung cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot